The global leader in healthcare naming!

Including nonproprietary (USAN/INN) names, drug brand names, medical device names, OTC product names, and COVID-19 vaccines, repurposed drugs, and diagnostics! We name over 75% of nonproprietary (USAN/INN) and drug brand name approvals worldwide!

1329
Healthcare Clients
4460
Total Healthcare Names
16
Obesity Names
Animal Health - 27
Antibiotic - 112
Antifungal - 28
Antiviral - 134
Antiviral/HIV - 52
Biologic Suffix - 62
Biosimilar Name - 29
Cardiovascular - 210
Class Name - 9
Clinical Trial Name - 120
Corporate Identity - 126
COVID-19 - 31
Covid-19 - 33
Dermatology - 149
Division Identity - 16
Endocrinology - 189
Gastrointestinal - 119
Hematology - 159
Identity Research - 15
Immunology - 261
Medical Device - 266
Men's Health - 11
Metabolic Disorders - 81
Musculoskeletal - 39
Nephrology - 34
Neurology - 389
Nutritional Agent - 53
Obesity - 16
Oncology - 818
Ophthalmology - 152
Oral Care - 8
OTC - 136
Pain & Inflammation - 171
Product Identity - 7
Program Name - 18
Respiratory - 221
Service Name - 17
Tagline - 12
Technology Name - 34
Urology - 26
USAN/INN - 1517
Vaccine - 107
Website - 24
Women's Health - 147
* Denotes a comprehensive report of the safety regulatory research prepared by B/DSI for submission of this name candidate to FDA, EMA, Health Canada, JMHLW, ANVISA, ROSZDRAVNADZOR, CDSCO, CFDA, KOREA MFDS, and/or other Regulatory Agencies.

CLIENTNAMECATEGORY
ALIZYMECETILISTAT Obesity
CITIUS PHARMASUPRENZA Obesity
EISAIBELVIQ *Obesity
GSKALLI Obesity
J&J INNOVATIVE MEDICINEefinopegdutide Obesity
NOVO NORDISKSAXENDA *Obesity
OREXIGEN THERAPEUTICSCONTRAVE *Obesity
PFIZERREDUX Obesity
RHYTHM PHARMACEUTICALSIMCIVREE *Obesity
RIEMSERALVALIN Obesity
ROCHEXENICAL Obesity
SANOFIACOMPLIA *Obesity
SHIONOGI PHARMAvelneperit Obesity
TAKEDAOBLEAN (オブリーン) Obesity
VIVUSQSYMIA *Obesity
ZAFGENaclimostat Obesity